Gyre Therapeutics
GYRE
GYRE
30 hedge funds and large institutions have $15M invested in Gyre Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
Holders
30
Holders Change
+9
Holders Change %
+42.86%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
8
Reduced
5
Closed
7
Calls
$1.04M
Puts
$15K
Net Calls
+$1.03M
Net Calls Change
-$500K
Top Buyers
| 1 |
1
BlackRock
New York
|
$5.96M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$3.1M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.15M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$2.76M |
| 5 |
5
Charles Schwab
San Francisco,
California
|
$275K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$0 |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
4
Balyasny Asset Management
Chicago,
Illinois
|
$0 |
| 5 |
5
JPMorgan Chase & Co
New York
|
$35.5K |
